Market Overview:
The global self-administered drugs market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in self-administered drug delivery devices. In addition, growing demand for home healthcare services is also propelling the growth of this market. However, stringent regulatory norms and reimbursement policies are restraining the growth of this market. Based on type, the global self-administered drugs market is segmented into injectable drugs, inhaled drugs, and transdermal drugs. Injectable drugs are further subsegmented into small molecules and biologics. Small molecules are further subsegmented into generic and branded products. The biologics segment is expected to grow at a higher CAGR during the forecast period owing to their high efficacy in treating chronic diseases such as cancer and diabetes mellitus (DM). Based on application, the global self-administered drug market is divided into cardiovascular diseases (CVDs), diabetes mellitus (DM), osteoporosis pain management , hormone replacement therapy (HRT), and others . Among these applications , CVDs held majority share in 2017 owing to high incidence rate of CVDs across globe . Hormone replacement therapy accounted for second largest share in 2017 due its ability improve quality life among postmenopausal women .
Product Definition:
Self-administered drugs are drugs that the individual takes into their own hands, as opposed to those that are prescribed by a physician. Self-administered drugs can be prescription medications or over-the-counter medications. These types of drugs can be important for individuals who need to take medication on a regular basis and may not have access to a physician or pharmacy.
Injectable Drugs:
Injectable drugs are a group of medications that are administered by injection. They may be formulated in different ways, such as ampoules or vials, and they can be given in various doses according to the medical condition of the patient. Injectables have certain advantages over oral medications; for instance, they can bypass the first pass metabolism and therefore reach systemic circulation directly.
Inhaled Drugs:
Inhaled drugs are administered by inhalation of the drug. The active pharmaceutical ingredient is absorbed in the lungs and then carried to systemic circulation. Inhaled drugs include bronchodilators, anti-inflammatory, antibiotics, analgesics and others.
The global inhaled drug market was valued at over USD 24 billion in 2014.
Application Insights:
The global self-administered drugs market is segmented by application into cardiovascular diseases, diabetes, osteoporosis pain management, hormone replacement and others. The cardiovascular diseases segment dominated the overall market in terms of revenue share in 2017. This can be attributed to the increasing prevalence of target disorders coupled with a growing geriatric population that is more susceptible to develop these disorders. As per the United States Census Bureau¢â‚¬â„¢s 2015 data, around 397 million adults aged 30 years or above were found in America which represented 26% of total U.S. population and this number is expected to increase till 2060 when around 542 million adults aged 30 years or above will be present which will represent 29% of total U.S.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, increasing geriatric population, and rising awareness about self-medication. Moreover, technological advancements such as miniaturization of inhalers and pumps for insulin are expected to drive the regional market over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period due to factors such as improving healthcare infrastructure and economic development in emerging countries like China & India.
Moreover, an increase in chronic diseases that require self-medication is also anticipated to boost product demand during the forecast period.
Growth Factors:
- Increasing geriatric population: The global geriatric population is expected to grow at a CAGR of 6.5% from 2016 to 2020, owing to the increase in life expectancy and the growth in the number of people aged 65 years and above. This will result in an increase in demand for self-administered drugs, as this population is more likely to require medication for chronic diseases.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, diabetes, and heart disease is increasing globally due to changing lifestyles and aging populations. This will lead to an increased demand for self-administered drugs as these patients are often required to take multiple medications on a daily basis.
- Technological advancements: There has been a significant advancement in drug delivery technologies over the past few years, which has led to the development of novel self-administered drugs such as inhalers and transdermal patches. These technological advancements are expected to drive market growth over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Self-administered Drugs Market Research Report
By Type
Injectable Drugs, Inhaled Drugs, Transdermal Drugs
By Application
Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Others
By Companies
Abbott Laboratories, Bristol-Myers Squibb, Novartis AG, Eli Lilly and Company, Gilead Sciences, Antares Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Self-administered Drugs Market Report Segments:
The global Self-administered Drugs market is segmented on the basis of:
Types
Injectable Drugs, Inhaled Drugs, Transdermal Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Bristol-Myers Squibb
- Novartis AG
- Eli Lilly and Company
- Gilead Sciences
- Antares Pharma
Highlights of The Self-administered Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injectable Drugs
- Inhaled Drugs
- Transdermal Drugs
- By Application:
- Cardiovascular Diseases
- Diabetes
- Osteoporosis
- Pain Management
- Hormone Replacement
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Self-administered Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Self-administered drugs are medications that a person takes without the help of a doctor or other medical professional. These medications can be taken orally, injected, or applied topically.
Some of the key players operating in the self-administered drugs market are Abbott Laboratories, Bristol-Myers Squibb, Novartis AG, Eli Lilly and Company, Gilead Sciences, Antares Pharma.
The self-administered drugs market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Self-administered Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Self-administered Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Self-administered Drugs Market - Supply Chain
4.5. Global Self-administered Drugs Market Forecast
4.5.1. Self-administered Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Self-administered Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Self-administered Drugs Market Absolute $ Opportunity
5. Global Self-administered Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Self-administered Drugs Market Size and Volume Forecast by Type
5.3.1. Injectable Drugs
5.3.2. Inhaled Drugs
5.3.3. Transdermal Drugs
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Self-administered Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Self-administered Drugs Market Size and Volume Forecast by Application
6.3.1. Cardiovascular Diseases
6.3.2. Diabetes
6.3.3. Osteoporosis
6.3.4. Pain Management
6.3.5. Hormone Replacement
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Self-administered Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Self-administered Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Self-administered Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Self-administered Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Self-administered Drugs Demand Share Forecast, 2019-2026
9. North America Self-administered Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Self-administered Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Self-administered Drugs Market Size and Volume Forecast by Application
9.4.1. Cardiovascular Diseases
9.4.2. Diabetes
9.4.3. Osteoporosis
9.4.4. Pain Management
9.4.5. Hormone Replacement
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Self-administered Drugs Market Size and Volume Forecast by Type
9.7.1. Injectable Drugs
9.7.2. Inhaled Drugs
9.7.3. Transdermal Drugs
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Self-administered Drugs Demand Share Forecast, 2019-2026
10. Latin America Self-administered Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Self-administered Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Self-administered Drugs Market Size and Volume Forecast by Application
10.4.1. Cardiovascular Diseases
10.4.2. Diabetes
10.4.3. Osteoporosis
10.4.4. Pain Management
10.4.5. Hormone Replacement
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Self-administered Drugs Market Size and Volume Forecast by Type
10.7.1. Injectable Drugs
10.7.2. Inhaled Drugs
10.7.3. Transdermal Drugs
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Self-administered Drugs Demand Share Forecast, 2019-2026
11. Europe Self-administered Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Self-administered Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Self-administered Drugs Market Size and Volume Forecast by Application
11.4.1. Cardiovascular Diseases
11.4.2. Diabetes
11.4.3. Osteoporosis
11.4.4. Pain Management
11.4.5. Hormone Replacement
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Self-administered Drugs Market Size and Volume Forecast by Type
11.7.1. Injectable Drugs
11.7.2. Inhaled Drugs
11.7.3. Transdermal Drugs
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Self-administered Drugs Demand Share, 2019-2026
12. Asia Pacific Self-administered Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Self-administered Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Self-administered Drugs Market Size and Volume Forecast by Application
12.4.1. Cardiovascular Diseases
12.4.2. Diabetes
12.4.3. Osteoporosis
12.4.4. Pain Management
12.4.5. Hormone Replacement
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Self-administered Drugs Market Size and Volume Forecast by Type
12.7.1. Injectable Drugs
12.7.2. Inhaled Drugs
12.7.3. Transdermal Drugs
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Self-administered Drugs Demand Share, 2019-2026
13. Middle East & Africa Self-administered Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Self-administered Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Self-administered Drugs Market Size and Volume Forecast by Application
13.4.1. Cardiovascular Diseases
13.4.2. Diabetes
13.4.3. Osteoporosis
13.4.4. Pain Management
13.4.5. Hormone Replacement
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Self-administered Drugs Market Size and Volume Forecast by Type
13.7.1. Injectable Drugs
13.7.2. Inhaled Drugs
13.7.3. Transdermal Drugs
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Self-administered Drugs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Self-administered Drugs Market: Market Share Analysis
14.2. Self-administered Drugs Distributors and Customers
14.3. Self-administered Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bristol-Myers Squibb
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Novartis AG
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Eli Lilly and Company
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Gilead Sciences
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Antares Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
